InvestSMART

EMvision Medical Devices Limited (ASX:EMV)

ALERT: Price-sensitive ASX Announcement for EMV
Current share price for EMV : $1.640 -0.265 (-13.91%)+
Announcement
Release
28 Oct 2025 8:18AM
Price at Release
$1.905
Full Release
download
Summary
EMVision Medical Devices Limited, an Australian company focused on developing portable brain scanners, reported a successful quarter ending on 30 September 2025. They raised $12 million through a placement and an additional $2 million through a Share Purchase Plan. The funds will support FDA submissions and commercial activities for their emu™ device and advance their First Responder program. Total cash reserves stood at $18.35 million, with additional non-dilutive funding available. Net operating cash outflows were $3.487 million, mainly attributed to R&D and staff costs. Key developments included progress in the Pivotal (Validation) Trial for the emu™ device, ethics approval for pre-hospital studies, and recognition through prestigious design awards.
Key Points
  • Successful $12 million placement and $2 million oversubscribed SPP.
  • Cash reserves of $18.35 million as of 30 September 2025.
  • Net operating cash outflows of $3.487 million.
  • Advancements in the emu™ Pivotal (Validation) Trial and pre-hospital studies.
  • Receipt of $400,000 milestone payment from the Australian Stroke Alliance.
  • Prestigious domestic and international design awards for the emu™ and First Responder devices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.